Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioharvest Sciences (BHST) Operating Expenses (2023 - 2025)

Bioharvest Sciences has reported Operating Expenses over the past 3 years, most recently at $45.8 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 26.92% year-over-year to $45.8 million; the TTM value through Dec 2025 reached $26.1 million, up 24.46%, while the annual FY2025 figure was $26.1 million, 24.46% up from the prior year.
  • Operating Expenses was $45.8 million for Q4 2025 at Bioharvest Sciences, up from -$6.5 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $45.8 million in Q4 2025 and bottomed at -$26.4 million in Q4 2023.
  • The 3-year median for Operating Expenses is -$4.9 million (2024), against an average of $2.6 million.
  • The widest YoY moves for Operating Expenses: up 236.79% in 2024, down 268.63% in 2024.
  • Over 3 years, Operating Expenses stood at -$26.4 million in 2023, then soared by 236.79% to $36.1 million in 2024, then rose by 26.92% to $45.8 million in 2025.
  • The last three reported values for Operating Expenses were $45.8 million (Q4 2025), -$6.5 million (Q3 2025), and -$6.9 million (Q2 2025) per Business Quant data.